I call this meeting to order.
Welcome to meeting number 10 of the Standing Committee on Science and Research. Pursuant to the House motion of June 18, the committee is meeting to study antimicrobial resistance.
I would like to make a few comments for the benefit of the witnesses and the members.
Please wait until I recognize you by name before speaking. For those participating by video conference, click on the microphone icon to activate your mic, and please mute yourself when you are not speaking.
For those on Zoom, at the bottom of your screen, you can select the appropriate channel for interpretation: floor, English or French. For those in the room, you can use the earpiece to select the desired channel.
As a reminder, all comments should be addressed through the chair.
I would like to welcome our three witnesses for the first panel and thank them for appearing before the committee today.
Joining us by video conference, we have Dr. Louis-Patrick Haraoui, associate professor at the faculty of medicine and health sciences at the Université de Sherbrooke; Dr. Gerry Wright, professor at the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University; and Professor Kevin Outterson, the founding executive director of CARB-X.
Welcome to all of the witnesses. You will each have five minutes for your opening remarks, and then we will go to our rounds of questioning.
We will begin with Dr. Haraoui. Please, go ahead.